← Leaderboards
Venigalla B. Rao
Brookhaven Science Assoc-Brookhaven Lab
$16,506,652
Attributed
$18,115,089
Total exposure
10
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.7M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$18,115,089 · 10
By mechanism
R01$9,992,447 · 4
U01$5,536,436 · 2
DP1$1,929,060 · 1
R21$348,355 · 1
P41$302,791 · 1
R13$6,000 · 1
Top collaborators
- Michael G Rossmann4 shared
- Rebecca E. Dutch1 shared
- Richard J. Kuhn1 shared
- Carolyn M Teschke1 shared
- Adam Zlotnick1 shared
Others in their field
Top investigators on “Bacteriophage T4”
- Stewart H Shuman · Sloan-Kettering Institute For Cancer Res$10,231,464
- Stephen J Benkovic · Scripps Research Institute$7,959,576
- Peter Hans Von Hippel · University Of Oregon$6,750,134
- Marlene Belfort · Wadsworth Center$5,160,004
- Michael G Rossmann · Purdue University West Lafayette$4,927,204
- Lindsay W Black · University Of Maryland Baltimore$4,700,728
Research focus
Bacteriophage T4CapsidParticleNanoparticleProteinsAntigensCapsid ProteinsDna PackagingCellsSurfaceEngineeringVirusImmune ResponseVaccinesBacteriophagesIn VitroDesignMotorNonhuman PrimateComplexImmunogenicityAdjuvantOryctolagus CuniculusHead
Grant awards (34)
Engineering Bacteriophage T4 as a Targeted Gene Therapy Drug for in vivo HIV Cure$964,530
DP1 · FY2025 · DA · contact PI
Structural Mechanisms Of Genome Flow In Bacteriophage T4 And Their Biomedical Applications$455,990
R01 · FY2025 · AI · contact PI
Engineering Bacteriophage T4 as a Targeted Gene Therapy Drug for in vivo HIV Cure$964,530
DP1 · FY2024 · DA · contact PI
Structural Mechanisms Of Genome Flow In Bacteriophage T4 And Their Biomedical Applications$470,093
R01 · FY2024 · AI · contact PI
Structural Mechanisms Of Genome Flow In Bacteriophage T4 And Their Biomedical Applications$484,843
R01 · FY2023 · AI · contact PI
Structural studies of bacteriophage T4 and their potential medical applications$638,825
R01 · FY2019 · AI
Single Dose, Multivalent, Anthrax Plague Vaccines using Bacteriophage T4 Nanopart$937,341
R01 · FY2018 · AI · contact PI
Structural studies of bacteriophage T4 and their potential medical applications$638,825
R01 · FY2018 · AI
Single Dose, Multivalent, Anthrax Plague Vaccines using Bacteriophage T4 Nanopart$776,353
R01 · FY2017 · AI · contact PI
Structural studies of bacteriophage T4 and their potential medical applications$638,825
R01 · FY2017 · AI
Structural studies of bacteriophage T4 and their potential medical applications$638,825
R01 · FY2016 · AI
Single Dose, Multivalent, Anthrax Plague Vaccines using Bacteriophage T4 Nanopart$636,281
R01 · FY2016 · AI · contact PI
Structural studies of bacteriophage T4 and their potential medical applications$652,575
R01 · FY2015 · AI
Single Dose, Multivalent, Anthrax Plague Vaccines using Bacteriophage T4 Nanopart$593,509
R01 · FY2015 · AI · contact PI
Potent Phage T4 Derived V2 Immunogens as HIV Vaccines$471,345
R01 · FY2015 · AI · contact PI
Single Dose, Multivalent, Anthrax Plague Vaccines using Bacteriophage T4 Nanopart$693,061
R01 · FY2014 · AI · contact PI
Potent Phage T4 Derived V2 Immunogens as HIV Vaccines$485,442
R01 · FY2014 · AI · contact PI
Multivalent Plague, Anthrax Vaccines Using Bacteriophage T4 Display$726,001
U01 · FY2013 · AI · contact PI
Potent Phage T4 Derived V2 Immunogens as HIV Vaccines$366,528
R01 · FY2013 · AI · contact PI
Multivalent Plague, Anthrax Vaccines Using Bacteriophage T4 Display$530,345
U01 · FY2012 · AI · contact PI
Potent Phage T4 Derived V2 Immunogens as HIV Vaccines$413,786
R01 · FY2012 · AI · contact PI
FASEB SRC on Virus Structure and Assembly$6,000
R13 · FY2012 · AI
Multivalent Plague, Anthrax Vaccines Using Bacteriophage T4 Display$474,542
U01 · FY2011 · AI · contact PI
Multivalent Plague, Anthrax Vaccines Using Bacteriophage T4 Display$251,990
U01 · FY2010 · AI · contact PI
Engineering a packaging nanomotor for delivery of RNA and other molecules$161,775
R21 · FY2010 · EB · contact PI
Multivalent Plague, Anthrax Vaccines Using Bacteriophage T4 Display$248,758
U01 · FY2009 · AI · contact PI
Engineering a packaging nanomotor for delivery of RNA and other molecules$186,580
R21 · FY2009 · EB · contact PI
A Multicomponent Anthrax Vaccine using Phage T4 Display$800,395
U01 · FY2007 · AI · contact PI
A Multicomponent Anthrax Vaccine using Phage T4 Display$825,803
U01 · FY2006 · AI · contact PI
A Multicomponent Anthrax Vaccine using Phage T4 Display$695,043
U01 · FY2005 · AI
A Multicomponent Anthrax Vaccine using Phage T4 Display$666,736
U01 · FY2004 · AI
A Multicomponent Anthrax Vaccine using Phage T4 Display$316,823
U01 · FY2003 · AI
STRUCTURE OF LARGE TERMINASE SUBUNIT FROM PHAGE T4$293,069
P41 · FY2001 · RR
STRUCTURE OF LARGE TERMINASE SUBUNIT FROM PHAGE T4$9,722
P41 · FY2000 · RR